Wipfli Financial Advisors LLC Takes Position in Ingevity Co. (NYSE:NGVT)

Wipfli Financial Advisors LLC acquired a new position in Ingevity Co. (NYSE:NGVTGet Rating) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 868 shares of the company’s stock, valued at approximately $53,000.

A number of other hedge funds have also bought and sold shares of NGVT. Geneos Wealth Management Inc. raised its holdings in shares of Ingevity by 96.4% during the second quarter. Geneos Wealth Management Inc. now owns 487 shares of the company’s stock valued at $30,000 after purchasing an additional 239 shares during the last quarter. Ronald Blue Trust Inc. raised its stake in Ingevity by 1,548.3% during the 3rd quarter. Ronald Blue Trust Inc. now owns 478 shares of the company’s stock valued at $31,000 after buying an additional 449 shares during the last quarter. Strs Ohio bought a new position in shares of Ingevity during the 2nd quarter valued at $37,000. EMC Capital Management boosted its stake in shares of Ingevity by 49.3% in the 2nd quarter. EMC Capital Management now owns 2,031 shares of the company’s stock worth $128,000 after buying an additional 671 shares during the last quarter. Finally, Trexquant Investment LP bought a new stake in shares of Ingevity in the second quarter worth $210,000. Hedge funds and other institutional investors own 90.01% of the company’s stock.

Insider Activity

In related news, insider Erik Spencer Ripple sold 856 shares of the company’s stock in a transaction on Friday, December 2nd. The shares were sold at an average price of $77.84, for a total value of $66,631.04. Following the completion of the transaction, the insider now owns 10,106 shares of the company’s stock, valued at approximately $786,651.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Ingevity news, insider Erik Spencer Ripple sold 856 shares of the company’s stock in a transaction that occurred on Friday, December 2nd. The stock was sold at an average price of $77.84, for a total value of $66,631.04. Following the completion of the transaction, the insider now directly owns 10,106 shares in the company, valued at approximately $786,651.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Richard Allen White, Jr. sold 1,639 shares of the stock in a transaction that occurred on Thursday, December 1st. The shares were sold at an average price of $77.97, for a total transaction of $127,792.83. Following the sale, the senior vice president now directly owns 3,995 shares of the company’s stock, valued at $311,490.15. The disclosure for this sale can be found here. Insiders own 0.71% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. BMO Capital Markets started coverage on Ingevity in a report on Tuesday, October 11th. They issued an “outperform” rating and a $87.00 target price on the stock. Wells Fargo & Company raised their price objective on shares of Ingevity from $73.00 to $76.00 and gave the stock an “equal weight” rating in a report on Monday, January 9th. Finally, StockNews.com cut shares of Ingevity from a “strong-buy” rating to a “buy” rating in a report on Friday, January 6th.

Ingevity Stock Up 1.8 %

NYSE NGVT opened at $81.64 on Monday. Ingevity Co. has a 52 week low of $56.31 and a 52 week high of $81.70. The company has a quick ratio of 1.25, a current ratio of 2.22 and a debt-to-equity ratio of 1.82. The company has a market capitalization of $3.05 billion, a P/E ratio of 14.05 and a beta of 1.78. The stock’s 50-day moving average price is $74.57 and its 200-day moving average price is $69.27.

Ingevity (NYSE:NGVTGet Rating) last released its earnings results on Wednesday, November 2nd. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.37. Ingevity had a net margin of 13.90% and a return on equity of 36.37%. The company had revenue of $482.00 million for the quarter, compared to analysts’ expectations of $428.39 million. On average, equities research analysts predict that Ingevity Co. will post 6.36 earnings per share for the current year.

About Ingevity

(Get Rating)

Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats.

Featured Stories

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.